BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23600864)

  • 1. Novel systemically active galanin receptor 2 ligands in depression-like behavior.
    Saar I; Lahe J; Langel K; Runesson J; Webling K; Järv J; Rytkönen J; Närvänen A; Bartfai T; Kurrikoff K; Langel Ü
    J Neurochem; 2013 Oct; 127(1):114-23. PubMed ID: 23600864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests.
    Lu X; Ross B; Sanchez-Alavez M; Zorrilla EP; Bartfai T
    Neuropeptides; 2008 Aug; 42(4):387-97. PubMed ID: 18554714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel GalR2-specific peptide agonist.
    Runesson J; Saar I; Lundström L; Järv J; Langel U
    Neuropeptides; 2009 Jun; 43(3):187-92. PubMed ID: 19467704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes.
    Lu X; Lundström L; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):165-7. PubMed ID: 15944007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of the chicken galanin receptor GalR2 and a novel GalR2-like receptor (GalR2-L).
    Ho JC; Jacobs T; Wang Y; Leung FC
    Gen Comp Endocrinol; 2012 Nov; 179(2):305-12. PubMed ID: 22982974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests.
    Barr AM; Kinney JW; Hill MN; Lu X; Biros S; Rebek J; Bartfai T
    Neurosci Lett; 2006 Sep; 405(1-2):111-5. PubMed ID: 16854525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel galanin receptor subtype specific ligand in depression like behavior.
    Saar I; Runesson J; Järv J; Kurrikoff K; Langel U
    Neurochem Res; 2013 Feb; 38(2):398-404. PubMed ID: 23192661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level.
    Kuteeva E; Wardi T; Lundström L; Sollenberg U; Langel U; Hökfelt T; Ogren SO
    Neuropsychopharmacology; 2008 Oct; 33(11):2573-85. PubMed ID: 18172432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
    Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
    Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions.
    Lundström L; Sollenberg UE; Bartfai T; Langel U
    J Neurochem; 2007 Dec; 103(5):1774-84. PubMed ID: 17953676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptors as a potential target for neurological disease.
    Freimann K; Kurrikoff K; Langel Ü
    Expert Opin Ther Targets; 2015; 19(12):1665-76. PubMed ID: 26220265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the galanin system by repeated electroconvulsive seizures in mice.
    Christiansen SH; Woldbye DP
    J Neurosci Res; 2010 Dec; 88(16):3635-43. PubMed ID: 20936701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
    Hawes JJ; Picciotto MR
    J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
    Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin receptor 2 overexpressing mice display an antidepressive-like phenotype: possible involvement of the subiculum.
    Le Maître TW; Xia S; Le Maitre E; Dun XP; Lu J; Theodorsson E; Ogren SO; Hökfelt T; Xu ZQ
    Neuroscience; 2011 Sep; 190():270-88. PubMed ID: 21672612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.